Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2zmd | 537 | Dual specificity protein kinase TTK | 2.7.12.1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
2zmd | 537 | Dual specificity protein kinase TTK | 2.7.12.1 | 1.000 | |
4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.635 | |
4bi1 | ZO6 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.634 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.632 | |
4c4i | X20 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.610 | |
4bi0 | Z0W | Dual specificity protein kinase TTK | 2.7.12.1 | 0.605 | |
5ap5 | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.588 | |
4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.523 | |
2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.514 | |
4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.507 | |
3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.505 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.503 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.501 | |
3icr | COA | Coenzyme A disulfide reductase | / | 0.498 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.493 | |
3vqu | O22 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.492 | |
4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.491 | |
5ap7 | SVE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.489 | |
3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.488 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.487 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.486 | |
3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.484 | |
2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.483 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.480 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.479 | |
2fvd | LIA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
2vgp | AD6 | Aurora kinase B-A | 2.7.11.1 | 0.479 | |
3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 0.479 | |
4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.477 | |
5awm | ANP | Stress-activated protein kinase JNK | 2.7.11.24 | 0.477 | |
4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.476 | |
4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.476 | |
2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.473 | |
3t2z | FAD | Sulfide-quinone reductase | / | 0.472 | |
4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.472 | |
4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.471 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.470 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.469 | |
2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.469 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.469 | |
1i7i | AZ2 | Peroxisome proliferator-activated receptor gamma | / | 0.468 | |
4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.468 | |
2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.467 | |
2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.467 | |
4hfm | NAP | 2-alkenal reductase (NADP(+)-dependent) | / | 0.467 | |
3vjh | J35 | Peroxisome proliferator-activated receptor gamma | / | 0.466 | |
2i4p | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.465 | |
2y03 | Y01 | Beta-1 adrenergic receptor | / | 0.465 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.465 | |
1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.464 | |
2i4z | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.463 | |
3cgf | JNF | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.462 | |
4b0g | VEK | Aurora kinase A | 2.7.11.1 | 0.462 | |
2npa | MMB | Peroxisome proliferator-activated receptor alpha | / | 0.461 | |
2qa2 | FAD | Polyketide oxygenase CabE | / | 0.461 | |
2y00 | Y01 | Beta-1 adrenergic receptor | / | 0.461 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.461 | |
4jaz | STL | Peroxisome proliferator-activated receptor gamma | / | 0.461 | |
1rdt | 570 | Peroxisome proliferator-activated receptor gamma | / | 0.460 | |
3ict | COA | Coenzyme A disulfide reductase | / | 0.460 | |
3lj3 | WYE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.460 | |
3qxp | X64 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.460 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.459 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.459 | |
3tm5 | SFG | Uncharacterized protein | / | 0.458 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.458 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.458 | |
4xld | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.458 | |
4xuh | SFI | Peroxisome proliferator-activated receptor gamma | / | 0.458 | |
2o2u | 738 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.457 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.456 | |
3tqh | NDP | Quinone oxidoreductase | / | 0.456 | |
4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.456 | |
4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.456 | |
2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
3fzt | 4JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.455 | |
3h0a | D30 | Peroxisome proliferator-activated receptor gamma | / | 0.455 | |
3orm | AGS | Serine/threonine protein kinase | / | 0.455 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.455 | |
2jn3 | JN3 | Fatty acid-binding protein, liver | / | 0.454 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.454 | |
3erk | SB4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.454 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.454 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.454 | |
3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.454 | |
4hee | 14R | Peroxisome proliferator-activated receptor gamma | / | 0.454 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.454 | |
4ydu | ADP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.453 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.453 | |
1hdc | CBO | 3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase | 1.1.1.53 | 0.452 | |
2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.452 | |
3t1t | GDP | Probable gliding protein mglA | / | 0.452 | |
3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.452 | |
2p9c | NAI | D-3-phosphoglycerate dehydrogenase | 1.1.1.95 | 0.451 | |
3i59 | N6R | CRP-like cAMP-activated global transcriptional regulator | / | 0.451 | |
3jqp | A2P | Ferredoxin--NADP reductase, apicoplast | / | 0.451 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.451 | |
3jyn | NDP | Quinone oxidoreductase | / | 0.450 | |
4bew | CZA | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.450 | |
5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.450 | |
2ohx | NAD | Alcohol dehydrogenase E chain | 1.1.1.1 | 0.449 | |
2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.449 | |
2y02 | Y01 | Beta-1 adrenergic receptor | / | 0.449 | |
3ics | COA | Coenzyme A disulfide reductase | / | 0.449 | |
3vso | EK1 | Peroxisome proliferator-activated receptor gamma | / | 0.449 | |
4ubs | DIF | Pentalenic acid synthase | 1.14.15.11 | 0.449 | |
2q59 | 240 | Peroxisome proliferator-activated receptor gamma | / | 0.448 | |
3s85 | LK0 | Gag-Pol polyprotein | / | 0.448 | |
3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.448 | |
3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.448 | |
4b7d | QLE | Cytochrome P450 monooxygenase PikC | / | 0.448 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.448 | |
4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.448 | |
4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.448 | |
4ma6 | 28E | Ara h 8 allergen | / | 0.448 | |
4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.448 | |
4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.448 | |
4xiw | AZM | Carbonic anhydrase, alpha type | / | 0.448 | |
2ay8 | 4TB | Aromatic-amino-acid aminotransferase | 2.6.1.57 | 0.447 | |
2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.447 | |
3lij | ANP | Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands | / | 0.447 | |
4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.447 | |
4iax | LIZ | Neutrophil gelatinase-associated lipocalin | / | 0.447 | |
1zeo | C01 | Peroxisome proliferator-activated receptor gamma | / | 0.446 | |
3ori | AGS | Serine/threonine protein kinase | / | 0.446 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
4h3q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.446 | |
4zoh | FAD | Putative oxidoreductase FAD-binding subunit | / | 0.446 | |
2b0m | 201 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.445 | |
2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.445 | |
2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.445 | |
3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.445 | |
3nx4 | NAP | Putative oxidoreductase | / | 0.445 | |
3t2k | FAD | Sulfide-quinone reductase | / | 0.445 | |
3v9v | 21L | Peroxisome proliferator-activated receptor gamma | / | 0.445 | |
4a31 | MYA | Glycylpeptide N-tetradecanoyltransferase | / | 0.445 | |
4bqp | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.445 | |
4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.445 | |
4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
4qe6 | JN3 | Bile acid receptor | / | 0.445 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
4e37 | NDP | Catalase | 1.11.1.6 | 0.444 | |
4e4q | RRH | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.444 | |
1qxl | FR8 | Adenosine deaminase | 3.5.4.4 | 0.443 | |
2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.443 | |
2prh | 238 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.443 | |
3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.443 | |
4uya | AGS | Mitogen-activated protein kinase kinase kinase 21 | 2.7.11.25 | 0.443 | |
1tz8 | DES | Transthyretin | / | 0.442 | |
2ph5 | NAD | Homospermidine synthase | / | 0.442 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.442 | |
3efw | AK8 | Aurora kinase A | 2.7.11.1 | 0.442 | |
3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.442 | |
3pgq | GY3 | Acetyl-CoA carboxylase | / | 0.442 | |
3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.442 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.442 | |
4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.442 | |
2e9c | B75 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.441 | |
2j3i | NAP | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.441 | |
2qo5 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.441 | |
2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.441 | |
2z7q | ACP | Ribosomal protein S6 kinase alpha-1 | 2.7.11.1 | 0.441 | |
3fro | NHF | GlgA glycogen synthase | / | 0.441 | |
3zxt | ACP | Death-associated protein kinase 1 | 2.7.11.1 | 0.441 | |
4a4v | YFD | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
4b4o | NDP | Epimerase family protein SDR39U1 | / | 0.441 | |
4bdd | Z0O | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
4h3c | 0YZ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.441 | |
5l7d | CLR | Smoothened homolog | / | 0.441 | |
1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.440 | |
1d3g | BRE | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.440 | |
1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.440 | |
1tvo | FRZ | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.440 | |
1v9a | SAH | Uncharacterized protein | / | 0.440 | |
2cf6 | NAP | Cinnamyl alcohol dehydrogenase 5 | 1.1.1.195 | 0.440 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.440 | |
3b6z | CO7 | Enoyl reductase LovC | 1 | 0.440 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.440 | |
3cgo | JNO | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.440 | |
4ez7 | 2AN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 |